Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
TAG Oil prepares for flow testing of its first unconventional oil well in Egypt (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Prophase Labs Inc PRPH

Healthcare
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its... see more

Recent & Breaking News (NDAQ:PRPH)

ProPhase Labs to Present at the LD Micro Main Event Conference

GlobeNewswire October 6, 2021

ProPhase Labs to Present at the Benzinga Healthcare Small Cap Conference

GlobeNewswire September 22, 2021

ProPhase Labs Announces $6 Million Stock Repurchase Program

GlobeNewswire September 8, 2021

ProPhase Labs to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference

GlobeNewswire September 7, 2021

ProPhase Labs to Present at Two Upcoming August Conferences

GlobeNewswire August 16, 2021

ProPhase Labs Announces Financial Results for the Quarter Ended June 30, 2021

GlobeNewswire August 13, 2021

ProPhase Labs Acquires Whole Genome Sequencing Company, Nebula Genomics

GlobeNewswire August 11, 2021

ProPhase Labs to Host Second Quarter 2021 Financial Results Conference Call on Friday, August 13, 2021 at 11:00 a.m. Eastern Time

GlobeNewswire August 9, 2021

ProPhase Labs to Present at the Access to Giving Virtual Investor Conference on July 15, 2021

GlobeNewswire July 12, 2021

ProPhase Labs Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services

GlobeNewswire July 1, 2021

ProPhase Labs Added to the Russell Microcap Index

GlobeNewswire June 28, 2021

ProPhase Labs Diversifies with Formation of Genomics and Global Healthcare Subsidiaries

GlobeNewswire June 10, 2021

ProPhase Labs to Present at LD Micro Invitational XI Virtual Conference

GlobeNewswire May 28, 2021

ProPhase Labs Reports First Quarter 2021 Financial Results and Announces $0.30 Special Cash Dividend

GlobeNewswire May 13, 2021

ProPhase Labs Partners With Dutchess County New York to Provide COVID-19 Testing

GlobeNewswire May 6, 2021

ProPhase Labs to Provide COVID-19 Testing for Oyster Bay Township in New York

GlobeNewswire April 22, 2021

ProPhase Labs Reports Fourth Quarter and Full Year 2020 Financial Results

GlobeNewswire March 31, 2021

ProPhase Labs Acquires Digital Covid Vaccination and Testing "Passport" Solution

GlobeNewswire March 30, 2021

ProPhase Labs to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Wednesday, March 31, 2021 at 4:30 p.m. Eastern Time

GlobeNewswire March 15, 2021

ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing for COVID-19, Influenza A & B, and Other Viruses After FDA Confirmation of Two Emergency Use Authorizations

GlobeNewswire February 9, 2021